Studies involving disease:Alzheimers disease
| Study ID | Study Title | Species | Institute |
|---|---|---|---|
| ST000046 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Human | Mayo Clinic |
| ST000047 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Human | Mayo Clinic |
| ST000433 | Plasma sphingolipid changes with autopsy-confirmed Lewy body or Alzheimer's pathology | Human | Mayo Clinic |
| ST000462 | CNS and peripheral metabolomics of calorie restriction in a mouse model of Alzheimer’s disease (part I) | Mouse | University of North Carolina |
| ST000463 | CNS and peripheral metabolomics of calorie restriction in a mouse model of Alzheimer’s disease (part II) | Mouse | University of North Carolina |
| ST001749 | REACH Metabolomics Study | Human | University of Wisconsin - Madison |
| ST001819 | EC and PVC from 14-15 month-old APOE3/3, APOE3/4 and APOE4/4 mice | Mouse | Columbia University |
| ST001820 | WT neurons treated with APOE3/3 and APOE4/4 ACM | Mouse | Columbia University |
| ST001848 | Untargeted mass spectrometry reveals impact of high fat diet on peripheral amino acid regulation in a mouse model of Alzheimer’s Disease | Mouse | Vanderbilt University |
| ST002213 | Metabolic changes in Alzheimer patient-derived induced neurons versus non-demented controls | Human | University of Colorado Denver |
| ST002214 | The effects of PKM2 modulation and hypoxia on the metabolic landscape of Alzheimer patient-derived induced neurons | Human | University of Colorado Denver |
| ST002334 | Phospholipase D3 impact on the endolysosomal lipidome | Human | VIB-KU Leuven |
